| Novo Nordisk Pharma AG - Tresiba Penfill, Injektionslösung |
| 62562 | | 01 | | Tresiba Penfill | | Injektionslösung | | A10AE06 | | Insulin Degludec | | 12.03.2013 | | |
|
| Composition |
| insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., glycerolum, zincum ut zinci acetas dihydricus, phenolum, metacresolum 1.72 mg, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insulinum Degludecum | 600 | | Nmol | |
| | BAG: Principe actif | Concentr. |
|---|
| Insulinum Degludecum | 100 U |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum ad Ph | | | Glycerol | | | Metacresol | 1.72 mg/ml | | Natrii Hydroxidum ad Ph | | | Phenol | | | Zincum | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 x 3 ml | 81.59 | 105.15 | B | LS | Oui |
|
